TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/14/24 17:33 | 6/14/24 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Dawes Karen A | MA | D | M.d | 200 | 67.71 | 0 | 3 | 3 | 88 | D | |||||||||||||||
2/28/24 21:56 | 2/27/24 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Dawes Karen A | MA | D | M.d | 195 | 42.07 | 0 | 5 | 6 | 87 | D | |||||||||||||||
2/28/24 21:56 | 2/27/24 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Dawes Karen A | MA | D | S.d | -193 | 193.35 | 0 | -1 | -1 | 87 | D | |||||||||||||||
8/30/23 16:06 | 8/29/23 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Dawes Karen A | MA | D | M.d | 134 | 18.12 | 0 | 7 | 10 | 84 | D | |||||||||||||||
8/30/23 16:06 | 8/29/23 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Dawes Karen A | MA | D | S.d | -146 | 171.38 | 0 | -1 | -1 | 84 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |